ClinVar Miner

Submissions for variant NM_001999.4(FBN2):c.728T>C (p.Ile243Thr)

gnomAD frequency: 0.00674  dbSNP: rs117524265
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 16
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000513981 SCV000168530 benign not provided 2021-02-10 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 16835936, 31426022)
Eurofins Ntd Llc (ga) RCV000179399 SCV000231644 benign not specified 2015-05-20 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000179399 SCV000308647 benign not specified criteria provided, single submitter clinical testing
Ambry Genetics RCV002310705 SCV000317900 benign Familial thoracic aortic aneurysm and aortic dissection 2015-02-11 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Illumina Laboratory Services, Illumina RCV000404713 SCV000452649 benign Congenital contractural arachnodactyly 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000404713 SCV000563020 benign Congenital contractural arachnodactyly 2024-01-31 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000513981 SCV000603692 benign not provided 2023-11-14 criteria provided, single submitter clinical testing
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics RCV000513981 SCV000609849 likely benign not provided 2017-08-10 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000513981 SCV000697903 benign not provided 2017-03-29 criteria provided, single submitter clinical testing Variant summary: The FBN2 c.728T>C (p.Ile243Thr) variant involves the alteration of a conserved nucleotide, resulting in a missense substitution. The variant lies within a TB domain (InterPro) and 3/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in the large control database ExAC at a frequency of 0.009478 (1150/121334 control chromosomes [18 homozygotes]), which is approximately 7582 times the estimated maximal expected allele frequency of a pathogenic FBN2 variant (0.0000013), suggesting this variant is likely a benign polymorphism. In a study of 49 Marfan syndrome or suspected Marfan syndrome patients where several disease-related genes were sequenced, including FBN2, the variant was detected and described as a polymorphism (Sakai_FBN1_AJMGA_2006). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as benign. Taken together, this variant is classified as benign.
Center for Human Genetics, Inc, Center for Human Genetics, Inc RCV000659594 SCV000781433 likely benign Connective tissue disorder 2016-11-01 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000513981 SCV002563855 benign not provided 2024-08-01 criteria provided, single submitter clinical testing FBN2: BS1, BS2
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV002277270 SCV002565962 benign Ehlers-Danlos syndrome 2021-11-13 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV000659594 SCV002566595 benign Connective tissue disorder 2021-08-04 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV000513981 SCV005225326 likely benign not provided criteria provided, single submitter not provided
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) RCV000513981 SCV001800741 likely benign not provided no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000179399 SCV001931263 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.